211 related articles for article (PubMed ID: 33566221)
41. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
[TBL] [Abstract][Full Text] [Related]
42. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
43. Wnt7a, frequently silenced by CpG methylation, inhibits tumor growth and metastasis via suppressing epithelial-mesenchymal transition in gastric cancer.
Liu Y; Qiao Y; Zhang H; Li W; Zheng J
J Cell Biochem; 2019 Oct; 120(10):18142-18151. PubMed ID: 31144375
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3.
Wang M; Wang X; Liu W
Mol Med Rep; 2020 Oct; 22(4):2990-3000. PubMed ID: 32945424
[TBL] [Abstract][Full Text] [Related]
45. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
[TBL] [Abstract][Full Text] [Related]
46. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
47. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A.
Hu Y; Wu F; Liu Y; Zhao Q; Tang H
Clin Epigenetics; 2019 Dec; 11(1):186. PubMed ID: 31810492
[TBL] [Abstract][Full Text] [Related]
48. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
49. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
50. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
51. Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
Zhang W; Wang H; Chen S; Fan X; Liu Y; Shi S; Wang R
Mol Carcinog; 2024 Jul; 63(7):1349-1361. PubMed ID: 38712797
[TBL] [Abstract][Full Text] [Related]
52. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
Zhang X; Cai D; Meng L; Wang B
Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
[TBL] [Abstract][Full Text] [Related]
54. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
55. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
Weng K; Li L; Zhou H
Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
[TBL] [Abstract][Full Text] [Related]
56. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
[TBL] [Abstract][Full Text] [Related]
57. FOXP3‑induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
Liu Y; Tu H; Zhang L; Xiong J; Li L
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880574
[TBL] [Abstract][Full Text] [Related]
58. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
59. Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway.
Mei Q; Li X; Zhang K; Wu Z; Li X; Meng Y; Guo M; Luo G; Fu X; Han W
Clin Cancer Res; 2017 Jan; 23(2):575-586. PubMed ID: 27503199
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
